Zanubrutinib Acid Impurity - Request Quote
Zanubrutinib Acid Impurity
| SZ CAT No: | SZ-Z011017 |
| CAS No | NA |
| Mol.F. | C24H26N4O3 |
| Mol.Wt. | 418.5 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Zanubrutinib Acid Impurity is chemically (S)-2-(4-phenoxyphenyl)-7-(piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxylic acid. Zanubrutinib Acid Impurity is supplied with detailed characterization data compliant with regulatory guideline. Zanubrutinib Acid Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Zanubrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Zanubrutinib Acid Impurity
Purchase Zanubrutinib Acid Impurity
Zanubrutinib Acid Impurity suppliers
Zanubrutinib Acid Impurity manufacturers
Zanubrutinib Acid Impurity price
Order Zanubrutinib Acid Impurity
Enquire Zanubrutinib Acid Impurity
Zanubrutinib Acid Impurity cost
Zanubrutinib Acid Impurity Supplier
Zanubrutinib Acid Impurity Distributor
Zanubrutinib Acid Impurity for Method Validation
Zanubrutinib Reference Standard
Zanubrutinib Acid Impurity for ANDA Filing
Zanubrutinib Acid Impurity for Forced Degradation Studies
Zanubrutinib Acid Impurity Identification Standards
Zanubrutinib Acid Impurity for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


